Mesenchymal stem cell therapy of intestinal disease: are their effects systemic or localized?

Area of Science:

• Gastroenterology
• Regenerative Medicine
• Cell Therapy

Background:

• Stem cell therapy is an emerging field in clinical gastroenterology.
• Mesenchymal stem cells (MSCs) are being investigated for various gastrointestinal diseases.
• Preclinical models have shown promise, with clinical trials now underway for conditions like inflammatory bowel disease.

Purpose of the Study:

• To review recent literature on mesenchymal stem cells (MSCs) for intestinal diseases.
• To explore the current understanding of MSC mechanisms in preclinical and clinical contexts.
• To highlight the therapeutic potential of MSCs in gastroenterology.

Main Methods:

• Literature review of studies published within the last two years.
• Analysis of research on mesenchymal stem cell (MSC) mechanisms of action.
• Examination of preclinical data and progression towards clinical trials.

Main Results:

• Significant advancements have been made in understanding MSC mechanisms.
• Two primary hypotheses explain MSC function: direct repair at injury sites or secretion of reparative and anti-inflammatory factors.
• Recent studies provide insights into how MSCs might exert therapeutic effects.

Conclusions:

• Mesenchymal stem cells (MSCs) demonstrate considerable therapeutic promise for various intestinal diseases.
• Further elucidation of MSC mechanisms is crucial for optimizing their clinical application.
• Continued research is expected to enhance the efficacy of MSC-based therapies in gastroenterology.